| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.23 | 5e-07 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |